Organ Preservation Market to Hit USD 455 Million by 2032 at a 6.4% of CAGR

The global organ preservation market is poised for steady growth, with its valuation expected to reach US$ 455 million by 2032, reflecting a compound annual growth rate (CAGR) of 6.4% over the forecast period. This growth is attributed to the increasing demand for organ transplants, rising cases of organ failure, and ongoing investments in healthcare infrastructure.

The growing prevalence of chronic diseases and organ-related disorders, such as chronic kidney disease (CKD), is driving demand for effective organ preservation solutions. As the number of patients requiring kidney transplants continues to rise, healthcare providers are focusing on improving the quality of organ preservation to ensure better transplant outcomes. Kidney transplants are particularly in demand, as kidney failure cases increase globally, fueled by conditions such as diabetes and hypertension.

The process of organ preservation involves maintaining the function of healthy organs from donors until transplantation into a recipient's body. One of the most widely used methods is static cold storage (SCS), which helps preserve organ function by slowing down metabolic activity and preventing the degradation of healthy tissue. Advances in preservation techniques and storage solutions are expected to enhance the success rate of transplants and drive further market growth.

Request a Sample of this Report Now:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14363

With rising healthcare investments, particularly in organ transplant programs and organ donation awareness campaigns, the market for organ preservation is set to expand. Key stakeholders are focused on the development of innovative preservation methods, such as machine perfusion and hypothermic perfusion, which offer better preservation outcomes and longer storage times compared to traditional methods.

Key Takeaways:

The global organ preservation market is projected to reach US$ 455 million by 2032, with a CAGR of 6.4%.
Rising demand for organ transplants and increased cases of organ failure are driving market growth.
Kidney transplants are a key driver, with growing cases of chronic kidney disease (CKD) and kidney failure.
Static cold storage (SCS) is the most commonly used preservation method, ensuring organ viability during storage and transport.
Investments in advanced organ preservation techniques, such as machine perfusion, are expected to support market expansion.

Market Drivers

Increasing Demand for Organ Transplants: The rising incidence of organ failures and the growing need for organ transplants are significant factors driving market growth. As chronic diseases become more prevalent, the demand for effective organ preservation methods is expected to rise.
Rising Cases of Kidney Failure: The increasing rates of kidney failure and chronic kidney disease are likely to boost kidney transplant rates, further propelling the organ preservation market.
Technological Advancements: Innovations in preservation techniques, such as static cold storage (SCS) and machine perfusion methods, are enhancing the viability of organs during transportation and storage.
Healthcare Investments: Increased investments in healthcare infrastructure and organ transplantation programs are expected to promote the growth of the organ preservation market.
Growing Awareness: Enhanced awareness about organ donation and transplantation processes is driving demand for effective preservation solutions that ensure successful transplant outcomes.

Challenges

Regulatory Hurdles: Navigating complex regulatory frameworks for organ preservation products can pose challenges for manufacturers.
Cost of Preservation Solutions: The high costs associated with advanced preservation technologies may limit accessibility for some healthcare facilities, particularly in developing regions.

Regional Insights

North America: Expected to dominate the market due to advanced healthcare infrastructure, high rates of organ transplants, and significant investments in research and development.
Asia-Pacific: Anticipated to exhibit the fastest growth rate driven by increasing healthcare funding, rising awareness of organ donation, and improvements in preservation technologies.

How is the Competitive Landscape for different Key Players of the Global Organ Preservation Market?

The key players in the organ preservation driving the global market are XVIVO Perfusion AB, Dr. Franz Kohler Chemie GmbH, Essential Pharmaceuticals LLC, Trans Medics, Organ Ox Limited, Shanghai Genext Medical Technology, Bridge to Life Limited, Waters Medical Systems, Preservation Solutions, Carnamedica, and Transplant Biomedicals.

All the prominent players dealing in organ preservation have continually adopted the advancing technologies and have changed the course of organ preservation from the past to the future to provide the best service for patients in need.

In recent years they have been focusing on mergers and collaboration to expand the customer base in traditionally less popular regions.

Some of the Recent Developments in the Organ Preservation Market:

Paragonix Technologies of the USA expanded its product offerings in the USA and Europe to strengthen its geographic presence by launching a LIVERgaurd Donor Liver Preservation System in 2021.
To gain access to transplantation networks in Latin America in 2021, XVIVO Perfusion of Sweden partnered with Contatti Medical of Brazil.
Institute Georges Lopez (IgI) of France set up a manufacturing facility in Tamil Nadu, India, in 2021 for expanding its business in medical devices and organ preservation solutions required for the flushing and preservation of organs.
OCS Heart System prepared by Transmedics company of USA received premedical approval from Food and Drug Administration (FDA) in 2021 for use with organs obtained from donors after brain death (DBD).
For the distribution and marketing of custodial HTK solutions in the Chinese and Asia Pacific markets Dr. Franz Köhler Chemie GmbH, Melchers Group, and CICEL of Germany started a joint venture in 2020 by the name of Köhler Pharmaceuticals in Beijing.

Key Segments

By Solution:

The University of Wisconsin Solution (UW Solution)
Custodial HTK
Perfadex
Other Solutions

By Technique:

Static Cold Storage
Hypothermia Machine Perfusion
Normothermic Machine Perfusion

By Organ Type:

Kidney
Liver
Long
Heart
Pancreas

By End User:

Organ Transplant Centres
Hospitals
Specialty Clinics

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa (MEA)

Explore FMI's Related Ongoing Coverage on Healthcare Market Insights Domain:

DNA Synthesis Market - https://www.futuremarketinsights.com/reports/dna-synthesis-market

Point Of Care Blood Testing Devices Market - https://www.futuremarketinsights.com/reports/point-of-care-blood-testing-devices-market

Pathology Imaging Systems Market - https://www.futuremarketinsights.com/reports/pathology-imaging-systems-market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

This release was published on openPR.